Aristotle Capital Boston’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-481,768
Closed -$14.3M 135
2021
Q4
$14.3M Sell
481,768
-4,792
-1% -$140K 0.33% 108
2021
Q3
$14.6M Sell
486,560
-1,884
-0.4% -$64.8K 0.34% 110
2021
Q2
$17.7M Sell
488,444
-41,202
-8% -$1.53M 0.41% 98
2021
Q1
$19.4M Buy
529,646
+3,363
+0.6% +$124K 0.43% 96
2020
Q4
$19.1M Sell
526,283
-50,189
-9% -$1.7M 0.45% 97
2020
Q3
$17.3M Buy
576,472
+7,292
+1% +$228K 0.5% 81
2020
Q2
$16.9M Buy
569,180
+70,753
+14% +$2.1M 0.51% 81
2020
Q1
$13.2M Buy
498,427
+10,166
+2% +$386K 0.57% 73
2019
Q4
$20.7M Sell
488,261
-24,283
-5% -$1.03M 0.57% 77
2019
Q3
$21.4M Buy
512,544
+54,718
+12% +$2.13M 0.63% 69
2019
Q2
$16.8M Buy
+457,826
New +$16.7M 0.53% 79

Other funds holding OHI

Aristotle Capital Boston's OHI Position: Q1 2022 in Review

Aristotle Capital Boston sold out of Omega Healthcare (OHI) in Q1 2022, closing a stake of 481,768 shares — an estimated $14.3M sold.

Aristotle Capital Boston first reported a position in OHI in Q2 2019 and held it in 11 quarters. The position peaked at $21.4M in Q3 2019. 488 funds tracked by Wall St. Rank hold OHI as of Q1 2022.

  • Aristotle Capital Boston reported no remaining Omega Healthcare position as of Q1 2022 after selling out during the quarter.
  • Aristotle Capital Boston sold 481,768 Omega Healthcare shares in Q1 2022, an estimated $14.3M.
  • Aristotle Capital Boston first reported a position in Omega Healthcare in Q2 2019 and held it in 11 quarters.
  • Aristotle Capital Boston's Omega Healthcare position peaked at $21.4M in Q3 2019.
  • 488 funds tracked by Wall St. Rank held Omega Healthcare as of Q1 2022.

Based on Aristotle Capital Boston's 13F filing for Q1 2022, filed 16 May 2022.